ArticleAdvances in experimental medicine and biology2026
Uncovering Key Genes in Neurodegenerative Diseases Through Unsupervised Learning: A Variance-Based LSTM and Enrichment Analysis Approach.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents an integrated approach for discovering and clustering significant genes associated with neurodegenerative diseases using a combination of variance-based filtering, Long Short-Term Memory (LSTM) neural networks, and enrichment analysis. By first filtering genes based on their variance across samples, we retain genes with high biological relevance. These selected genes are then used to train an LSTM model, capturing complex interactions between gene expression patterns. Using Uniform Manifold Approximation and Projection (UMAP) for dimensionality reduction and K-Means for clustering, we group genes with similar expression profiles. The optimal number of clusters is determined using the Silhouette Score. To refine the model, we introduce a feedback loop where cluster labels are fed back into the LSTM as additional features, enhancing the model's ability to detect significant gene associations. We compare various network architectures to assess their impact on clustering performance. Finally, enrichment analysis reveals key biological pathways, such as immune regulation and protein signaling, related to Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Our approach demonstrates the potential of machine learning and clustering to uncover meaningful gene associations, offering insights into the molecular mechanisms underlying neurodegenerative diseases.
Indexed as
Identifiers
41273593What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.